pre-miRNA Information
pre-miRNA hsa-mir-3675   
Genomic Coordinates chr1: 16858949 - 16859021
Description Homo sapiens miR-3675 stem-loop
Comment None
RNA Secondary Structure

Mature miRNA Information
Mature miRNA hsa-miR-3675-5p
Sequence 12| UAUGGGGCUUCUGUAGAGAUUUC |34
Evidence Experimental
Experiments Illumina
SNPs in miRNA
Mutant ID Mutant Position Mutant Source
rs1229940041 1 dbSNP
rs1184422098 2 dbSNP
rs768029583 3 dbSNP
rs202014433 6 dbSNP
rs774834919 7 dbSNP
rs1484376029 8 dbSNP
rs771338088 8 dbSNP
rs749521347 10 dbSNP
rs773421450 12 dbSNP
rs1250672393 14 dbSNP
rs769780471 15 dbSNP
rs781028022 16 dbSNP
rs1315377622 17 dbSNP
rs754885466 18 dbSNP
rs746860289 20 dbSNP
rs1330333643 23 dbSNP
Putative Targets

miRNA Expression profile
miRNAs in Extracellular Vesicles
Circulating MicroRNA Expression Profiling
Gene Information
Gene Symbol MRPL34   
Synonyms L34mt
Description mitochondrial ribosomal protein L34
Transcript NM_023937   
Expression
Putative miRNA Targets on MRPL34
3'UTR of MRPL34
(miRNA target sites are highlighted)
>MRPL34|NM_023937|3'UTR
   1 GGATCGCGACGCAGTCGGCGGGACCCTCATGGAAGCATCGCCCTCGCCTCGGACCTTGCCTGGCGCTATTTTTGCAGGGA
  81 GCTGGGGAGCAGGAACGCCTCGGACCTGAGTGCTCTCCATATTGTGGGGTTGAAGTCTGGATGGGAGCTTGCCAAGTCCC
 161 TTTTTAGGCTTTTTAATTAGGAAGCATTTCGAACCTGCGCAACAGACCAAAGAACAGTACAAAGAACATCCGTGTACCCA
 241 GTACCCTGACTACCGACTACCTACAACCCGTCCCTGCCCCATCCTGAGTTCTTTTGAAGCTGATCTCAGGCATCGGATTA
 321 TTTCTTCTGTAAATATTTCAGAATGTATCTCTCCAAGATGAGAGCTCATTAAAAGACAATTACAAAGCTTATCACATCCA
 401 AAAGAATTATCAATAATTTTGAAATATTATTAAACGTGTAATAAATGTTCAAAGTTCCACTTGC
Target sites Provided by authors   Predicted by miRanda    DRVs    SNPs    DRVs & SNPs
miRNA-target interactions
(Predicted by miRanda)
ID Duplex structure Position Score MFE
1
miRNA  3' cuuuagagaugucuuCGGGGUAu 5'
                         ||||||| 
Target 5' ctacaacccgtccctGCCCCATc 3'
261 - 283 140.00 -11.92
2
miRNA  3' cuuuagAGAUGUCUUCGGGGUAu 5'
                || :|:|:| ||:||| 
Target 5' acgcagTCGGCGGGACCCTCATg 3'
9 - 31 117.00 -16.60
3
miRNA  3' cuUUAGAGAUGUCUUCGGGGUau 5'
            ||| |:  || |||::|||  
Target 5' taAATGTT--CA-AAGTTCCAct 3'
442 - 461 108.00 -7.00
DRVs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
COSN31538947 41 COSMIC
COSN30513199 68 COSMIC
COSN28195016 98 COSMIC
COSN28865089 166 COSMIC
COSN32056007 191 COSMIC
COSN21843390 318 COSMIC
COSN6138826 443 COSMIC
SNPs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
rs752128680 2 dbSNP
rs553287368 6 dbSNP
rs113881312 9 dbSNP
rs567182216 16 dbSNP
rs775226742 19 dbSNP
rs1306502144 21 dbSNP
rs1202012640 24 dbSNP
rs1242309642 25 dbSNP
rs1234073161 26 dbSNP
rs1235939361 27 dbSNP
rs762892120 28 dbSNP
rs763546639 31 dbSNP
rs1185140241 38 dbSNP
rs1251027685 41 dbSNP
rs773882196 42 dbSNP
rs1172931853 44 dbSNP
rs1337342256 46 dbSNP
rs1418542511 47 dbSNP
rs1051157112 49 dbSNP
rs761362721 51 dbSNP
rs1401364143 52 dbSNP
rs891222128 56 dbSNP
rs2288464 65 dbSNP
rs1343485607 67 dbSNP
rs1037070369 73 dbSNP
rs182592588 77 dbSNP
rs1415170836 80 dbSNP
rs868045144 87 dbSNP
rs1407461949 92 dbSNP
rs898738297 94 dbSNP
rs144555991 104 dbSNP
rs1044076185 106 dbSNP
rs1187723662 110 dbSNP
rs905536916 114 dbSNP
rs1023657482 117 dbSNP
rs930367667 118 dbSNP
rs564763374 120 dbSNP
rs1003461549 127 dbSNP
rs1212328242 129 dbSNP
rs1034736706 132 dbSNP
rs533367911 133 dbSNP
rs1271090480 137 dbSNP
rs1283071559 143 dbSNP
rs868201061 146 dbSNP
rs547221034 148 dbSNP
rs1288714794 154 dbSNP
rs1232528097 161 dbSNP
rs1353469371 161 dbSNP
rs113679687 169 dbSNP
rs1019188556 182 dbSNP
rs544569057 191 dbSNP
rs1195925420 198 dbSNP
rs1316434756 199 dbSNP
rs996172102 200 dbSNP
rs1413058081 208 dbSNP
rs558325863 217 dbSNP
rs566716672 226 dbSNP
rs967920486 231 dbSNP
rs979346987 238 dbSNP
rs1472812436 246 dbSNP
rs921190872 250 dbSNP
rs932466112 253 dbSNP
rs1240990388 255 dbSNP
rs1051371515 256 dbSNP
rs1031534663 264 dbSNP
rs1448366398 267 dbSNP
rs1268435172 273 dbSNP
rs1212778783 291 dbSNP
rs1332423290 325 dbSNP
rs578144449 328 dbSNP
rs770172681 331 dbSNP
rs546010040 336 dbSNP
rs1268485779 348 dbSNP
rs187111045 352 dbSNP
rs773606046 354 dbSNP
rs1424904096 360 dbSNP
rs988645617 372 dbSNP
rs192025106 377 dbSNP
rs6903 378 dbSNP
rs1397168946 380 dbSNP
rs1165987756 388 dbSNP
rs1428408564 395 dbSNP
rs898478826 396 dbSNP
rs182918642 397 dbSNP
rs779144283 407 dbSNP
rs748672533 415 dbSNP
rs1184247312 427 dbSNP
rs758921554 436 dbSNP
rs1450809025 448 dbSNP
rs530435720 456 dbSNP
Experimental Support 1 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
Conditions C8166
Location of target site 3'UTR
Tools used in this research TargetScan , miRTarCLIP , Piranha
Original Description (Extracted from the article) ... PAR-CLIP data was present in GSM1462572. RNA binding protein: AGO2. Condition:C8166 NL4-3 ...

- Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio.

miRNA-target interactions (Provided by authors)
ID Duplex structure Position
1
miRNA  3' cuuuagagaugucuuCGGGGUau 5'
                         ||||||  
Target 5' -----acccgucccuGCCCCA-- 3'
1 - 16
Article - Whisnant AW; Bogerd HP; Flores O; Ho P; et al.
- mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
CLIP-seq Support 1 for dataset GSM1462572
Method / RBP PAR-CLIP / AGO2
Cell line / Condition C8166 / C8166 NL4-3
Location of target site ENST00000252602.1 | 3UTR | ACCCGUCCCUGCCCCA
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Article / Accession Series PMID: 23592263 / GSE59944
CLIP-seq Viewer Link
MiRNA-Target Expression Profile
Dataset Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
MiRNA-Target Expression Profile (TCGA)
Tumor Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
32 hsa-miR-3675-5p Target Genes:
Functional analysis:
ID Target Description Validation methods
Strong evidence Less strong evidence
MIRT366903 NONO non-POU domain containing octamer binding 2 2
MIRT453894 DUSP18 dual specificity phosphatase 18 2 2
MIRT461725 ZNF426 zinc finger protein 426 2 2
MIRT464694 UBE2V1 ubiquitin conjugating enzyme E2 V1 2 2
MIRT465957 TMEM189-UBE2V1 TMEM189-UBE2V1 readthrough 2 2
MIRT466038 TMEM189 transmembrane protein 189 2 2
MIRT471546 PAX5 paired box 5 2 2
MIRT472813 MTMR12 myotubularin related protein 12 2 2
MIRT474099 LMBR1L limb development membrane protein 1 like 2 2
MIRT480205 CAD carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase 2 2
MIRT488268 HSP90AB1 heat shock protein 90 alpha family class B member 1 2 8
MIRT491222 MRPL34 mitochondrial ribosomal protein L34 2 2
MIRT494768 AP1G1 adaptor related protein complex 1 gamma 1 subunit 2 2
MIRT497228 MORC2 MORC family CW-type zinc finger 2 2 2
MIRT501676 PFN1 profilin 1 2 6
MIRT511831 H2AFX H2A histone family member X 2 4
MIRT513880 HNRNPUL1 heterogeneous nuclear ribonucleoprotein U like 1 2 4
MIRT519402 DNASE2 deoxyribonuclease 2, lysosomal 2 4
MIRT522627 MAP7D1 MAP7 domain containing 1 2 4
MIRT546998 PPP2CA protein phosphatase 2 catalytic subunit alpha 2 2
MIRT555119 PUM2 pumilio RNA binding family member 2 2 2
MIRT560380 TIMM8A translocase of inner mitochondrial membrane 8A 2 2
MIRT572188 CDADC1 cytidine and dCMP deaminase domain containing 1 2 2
MIRT634822 ASB6 ankyrin repeat and SOCS box containing 6 2 2
MIRT641149 DNMBP dynamin binding protein 2 2
MIRT647389 ZNF616 zinc finger protein 616 2 2
MIRT670851 SFT2D2 SFT2 domain containing 2 2 2
MIRT698600 TEX261 testis expressed 261 2 2
MIRT698691 TBPL1 TATA-box binding protein like 1 2 2
MIRT708725 PTPLAD2 3-hydroxyacyl-CoA dehydratase 4 1 1
MIRT718340 SYNDIG1L synapse differentiation inducing 1 like 2 2
MIRT725514 FBXO46 F-box protein 46 2 2
miRNA-Drug Resistance Associations
miRNA Drug Name CID NSC FDA Effect/Pattern Detection Method Level Phenotype Condition
hsa-mir-3675 Doxorubicin 31703 NSC123127 approved sensitive High Triple-Negative Breast Cancer cell line (MDA-MB-231, MDA-MB-468)
hsa-miR-3675-5p Cisplatin 5460033 NSC119875 approved resistant cell line (MGC-803)
hsa-miR-3675-5p Cisplatin 5460033 NSC119875 approved sensitive cell line (A549)

Error report submission